论文部分内容阅读
本文对82例妇科肿瘤患者进行了铜兰蛋白(ceruloplasmin,CER)和C—反应蛋白(C—reactive-protein,CRP)的检测,并观察手术前后或化疗后含量的变化,同时选择20例健康人作对照,并做了如下分析研究,现报道如下:1.临床资料1·1 一般资料 肿瘤患者82例,系本院住院和门诊病人。均经本院病理确诊。年龄在35～74岁。20例健康对照组,均为健康体检者,体检仅有关化验检查均为正常,年龄在25～60岁。1·2 测定方法;采用速率散射免疫浊度法。用美国贝克曼(Backman)公司的ARRAY360系统进行测定,各种配套试剂均由该公司提供。CRP测定采用单向琼脂
In this paper, 82 cases of gynecologic cancer patients were tested for ceruloplasmin (CER) and C-reactive-protein (CRP), and the changes of the content before and after or after chemotherapy were observed. At the same time, 20 cases of health were selected. People as a control, and made the following analysis and research, are reported as follows: 1. Clinical data 1. 1 General Information 82 patients with cancer, the hospital in and outpatients. All were pathologically diagnosed in our hospital. Age 35 to 74 years old. The 20 healthy control groups were all healthy checkups. The physical examinations were only normal and the ages ranged from 25 to 60 years. 1 2 determination method; using rate-scattering immunoturbidimetry. The measurement was performed using the ARRAY 360 system from Backman, Inc., USA. Various reagents were supplied by the company. CRP assay using unidirectional agar